Dividend Assets Capital LLC Has $11.36 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Dividend Assets Capital LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.1% in the fourth quarter, HoldingsChannel reports. The fund owned 22,463 shares of the healthcare conglomerate’s stock after acquiring an additional 680 shares during the period. UnitedHealth Group makes up 2.2% of Dividend Assets Capital LLC’s portfolio, making the stock its 15th largest position. Dividend Assets Capital LLC’s holdings in UnitedHealth Group were worth $11,363,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. AlphaMark Advisors LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $30,000. RPg Family Wealth Advisory LLC bought a new position in shares of UnitedHealth Group during the 3rd quarter worth approximately $37,000. DecisionPoint Financial LLC raised its stake in UnitedHealth Group by 155.0% in the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after acquiring an additional 62 shares during the period. Highline Wealth Partners LLC bought a new position in shares of UnitedHealth Group in the third quarter valued at about $55,000. Finally, Legacy Investment Solutions LLC bought a new stake in shares of UnitedHealth Group during the 3rd quarter worth about $57,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on UNH shares. Stephens raised their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a research report on Friday, January 10th. Piper Sandler lowered their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Stock Down 7.3 %

NYSE:UNH opened at $465.58 on Friday. The company has a market cap of $428.46 billion, a PE ratio of 30.04, a P/E/G ratio of 1.37 and a beta of 0.61. The firm’s 50 day simple moving average is $519.27 and its 200 day simple moving average is $560.54. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the previous year, the company posted $5.83 EPS. The business’s revenue was up 6.8% on a year-over-year basis. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.